Causes of Elevated LFTs and Alkaline Phosphatase
Yes, numerous drugs and diseases cause elevated LFTs and alkaline phosphatase, with the pattern of elevation (hepatocellular vs. cholestatic) being critical for narrowing the differential diagnosis.
Pattern Recognition is Key
The approach to elevated LFTs and ALP depends fundamentally on whether you're seeing a hepatocellular pattern (aminotransferases >> ALP) or a cholestatic pattern (ALP elevated disproportionately to aminotransferases) 1.
Hepatocellular Pattern (ALT/AST Predominant)
When aminotransferases are elevated much higher than ALP, consider:
Most Common Causes:
- Nonalcoholic fatty liver disease (NAFLD) - prevalence 20-30% in general population, up to 70% with obesity, 90% with diabetes 1
- Alcohol-induced liver disease - typically shows AST:ALT ratio >2 (vs. <1 in NAFLD) 1, 2
Uncommon but Important:
- Drug-induced liver injury (medications/toxins)
- Viral hepatitis (B and C)
- Hereditary hemochromatosis
- Acute Budd-Chiari syndrome
- Ischemic hepatitis 1
Rare Causes:
- Alpha-1-antitrypsin deficiency
- Autoimmune hepatitis
- Wilson disease 1
Critical Pitfall: If AST is predominantly elevated over ALT, consider non-hepatic causes including hemolysis, myopathy, thyroid disease, and exercise 1.
Cholestatic Pattern (ALP Predominant)
When ALP is elevated with or without elevated bilirubin, the differential shifts dramatically:
Extrahepatic Biliary Obstruction:
- Choledocholithiasis - most common cause 1
- Malignant obstruction
- Biliary strictures
- Infections (AIDS cholangiopathy, liver flukes) 1
Intrahepatic Cholestasis:
- Primary biliary cholangitis
- Primary sclerosing cholangitis
- Drug-induced cholestasis 1, 3
- Infiltrative diseases (sarcoidosis, amyloidosis, hepatic metastases) 1
Malignancy - The Critical Diagnosis: In a recent observational study of isolated elevated ALP, malignancy accounted for 57% of cases, with 61 patients having infiltrative intrahepatic malignancy, 52 having bony metastasis, and 34 having both 4. Notably, 47% of these patients died within an average of 58 months, underscoring the clinical significance of unexplained ALP elevation.
Other Important Causes:
- Bone disease (29% in one series) - Paget's disease, bony metastases, fractures 1, 4, 5
- Sepsis - can cause extremely high ALP (>1000 U/L) even with normal bilirubin 5
- NAFLD can present with isolated ALP elevation, particularly in older females 6
Drug-Induced Causes
Medications causing elevated LFTs and ALP include:
- Statins (particularly atorvastatin) - can cause impressive ALP elevations, especially when combined with CYP3A4 inhibitors like clopidogrel or nifedipine 3
- Papaverine hydrochloride - documented to elevate transaminases and ALP 7
- Various hepatotoxic drugs causing cholestatic injury 8, 1
Critical Point: Always obtain a detailed medication inventory including vitamins, herbs, and over-the-counter drugs 8.
Confirming Hepatic Origin of ALP
Use gamma-glutamyl transpeptidase (GGT) to confirm hepatic origin of elevated ALP. GGT is found in liver but not bone, so concomitantly elevated GGT confirms the ALP originates from liver and indicates cholestasis 1.
Special Populations
AIDS patients warrant particular attention - they can have elevated ALP from sepsis, MAI infection, CMV infection, or drug toxicity 5.
Older females with isolated ALP elevation and metabolic risk factors should be evaluated for NAFLD with potential advanced disease 6.
Important Caveats
- Normal LFTs do not completely exclude hepatic disease 8
- Sepsis can cause extremely high ALP with normal bilirubin - don't be falsely reassured 5
- Liver disease can transiently normalize or elevate ALP in patients with hypophosphatasia, potentially masking the underlying diagnosis 9
- The AST/ALT ratio >1.5 suggests alcoholic liver disease (62% sensitivity) vs. MASLD (28%) 2